In Brief: Positron
This article was originally published in The Gray Sheet
Positron: President and CEO Werner Haas, PhD, resigns, the firm announced in an April 11 release. Chairman of the Board Gary Wood has assumed Haas' duties. The Houston firm is "currently experiencing liquidity problems" and "has recently been unable to pay certain of its obligations within their standard payment date," according to the release. Additionally, Positron's pending acquisition of GE Medical Systems' positron emission tomography assets ("The Gray Sheet" July 22, 1996, I&W-5) has been "delayed." Although the two firms remain in negotiations over the deal, GEMS is free to negotiate with other companies because the transaction did not close by March 31, Positron notes...
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.